Bobby Riehle, Ph.D.

Bobby Riehle, Ph.D., was named Vice President, Head of Program Strategy in June 2025. Bobby is responsible for the leadership and execution of Fulcrum’s portfolio of clinical-stage assets, including Program Management and New Product Planning. Since joining Fulcrum in 2019, Bobby has held leadership roles in Program Leadership, Corporate Strategy and New Product Planning. Prior to Fulcrum, Bobby was a consultant focusing on commercial, portfolio and corporate strategy at Trinity Partners and Treacy & Company.

Bobby received a Ph.D. in Pharmaceutics and Drug Delivery from Northeastern University and a B.S. in Polymer Chemistry from North Carolina State University.